Abstract
The treatment of rheumatic diseases of juxta-articular soft tissues (RDJAST) of the upper extremity (rotator cuff tendinitis, epicondylitis, de Quervain’s syndrome, trigger finger, carpal tunnel syndrome) entails a combination of drug and nondrug therapies. The basic agents that have been proven to be efficacious in this pathology are nonsteroidal anti-inflammatory drugs (NSAIDs) and glucocorticosteroids (GCs). The paper considers the largest and known studies that are an evidence base for the expediency of using agents, such NSAIDs, local administration of GCs, hyaluronic acid, and plateletrich plasma, as well as different non-drug treatments, in RDJAST. The latter (physiotherapy, exercises, and rehabilitation programs) should be regarded as a necessary component of the therapeutic process in patients with RDJAST-associated chronic pain. Preservation of obvious pain and impaired function despite medical therapy should be regarded as an indication for surgical treatment.
Highlights
Minor rheumatology: Nonsystemic rheumatic disease of juxta-articular soft tissues of the upper extremity
The basic agents that have been proven to be efficacious in this pathology are nonsteroidal anti-inflammatory drugs (NSAIDs) and glucocorticosteroids (GCs)
Preservation of obvious pain and impaired function despite medical therapy should be regarded as an indication for surgical treatment
Summary
Но кратковре- Быстрое, но кратковре- Стойкий эффект в тече- Быстрый, менное уменьшение боли менное уменьшение боли ние 12 мес у 50–70% боль- но кратковременный (3–6 нед); небольшое (3–6 нед); небольшое ных после 1–2 инъекций; эффект (2–4 нед) нарастание эффекта при нарастание эффекта при возможность поддержаповторных инъекциях повторных инъекциях ния ремиссии при повторных инъекциях
Sign-in/Register to view highlights & summary 
Published Version (
Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call